Clinical value of MLH1-negative circulating tumor cells in lung cancer patients

Circulating tumor cells (CTCs) serve as valuable biomarkers. However, MutL homolog 1 (MLH1)-negative CTCs and their clinical significance in lung cancer are nearly unknown. Here, bioinformatic analysis of MLH1 expression and its clinical significance was conducted using the Oncomine, Ualcan, and Kap...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Jin-Yan, Yang, Qi-Fan, Zeng, Yu-Lan, Liu, Yang-Yang, Liu, Yu-Ting, Gu, Fei-Fei, Hu, Yue, Zhang, Kai, Zhong, Hao, Liu, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636948/
https://www.ncbi.nlm.nih.gov/pubmed/31232917
http://dx.doi.org/10.1097/MD.0000000000015721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636948/
https://www.ncbi.nlm.nih.gov/pubmed/31232917
http://dx.doi.org/10.1097/MD.0000000000015721

Ejemplares similares